ANIKA THERAPEUTICS INC (ANIK)
US0352551081 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to ANIK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.94. This target is 21% above the current price.
ANIK was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ANIK.
In the previous month the buy percentage consensus was at a similar level.
ANIK was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-14 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-01-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-08-14 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-08-10 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-31 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-04-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-03-07 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2022-11-09 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2022-10-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2022-03-09 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2021-11-16 | Stephens & Co. | Initiate | Overweight |
| 2021-07-16 | UBS | Initiate | Neutral |